Young David Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$350,032.35
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Young David

According to the SEC Form 4 filings, Young David, being in a position of

  1. Pres. Research & Development at Processa Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 12990 shares for $32,418, and sold 0 shares,
    over all time since 2021-06-23, has bought 308490 shares for $382,451, and sold 0 shares.

Biography of Young David

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $32,4187100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-06-30PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Pres. Research & Development
2,531
0.1123%
$1.93$4,885+5.99%
2026-06-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Pres. Research & Development
2,067
0.0916%
$2.22$4,589-8.37%
2026-05-29PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Pres. Research & Development
1,786
0.0791%
$2.57$4,590-19.92%
2026-05-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Pres. Research & Development
1,545
0.0684%
$2.97$4,589-30.07%
2026-04-30PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Pres. Research & Development
1,706
0.0764%
$2.69$4,589-22.22%
2026-04-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Pres. Research & Development
1,545
0.0684%
$2.97$4,589-28.04%
2026-03-31PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Pres. Research & Development
1,810
0.0802%
$2.54$4,588-15.02%
2025-01-27PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Pres. Research & Development
124,500
4.3802%
$0.80$99,289-58.6%
2024-02-07PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Pres. Research & Development
21,000
0.9297%
$2.45$51,526-31.39%
2024-02-06PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Pres. Research & Development
20,000
0.9113%
$2.53$50,504-35.71%
2023-06-12PurchaseProcessa Pharmaceuticals, Inc.
PCSA
President & CEO
40,000
0.1925%
$0.80$32,000-58.56%
2023-04-14PurchaseProcessa Pharmaceuticals, Inc.
PCSA
President & CEO
20,000
0.0966%
$0.55$10,998-25.8%
2023-04-13PurchaseProcessa Pharmaceuticals, Inc.
PCSA
President & CEO
20,000
0.0897%
$0.48$9,600-21.06%
2023-04-12PurchaseProcessa Pharmaceuticals, Inc.
PCSA
President & CEO
20,000
0.0898%
$0.45$9,000-15.23%
2023-04-11PurchaseProcessa Pharmaceuticals, Inc.
PCSA
President & CEO
20,000
0.0993%
$0.52$10,400-18.15%
2021-06-23PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Executive Officer
10,000
0.0661%
$7.67$76,716-34.86%
Total: 16
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.